Cargando…
Actionable Molecular Alterations Are Revealed in Majority of Advanced Non-Small Cell Lung Cancer Patients by Genomic Tumor Profiling at Progression after First Line Treatment
SIMPLE SUMMARY: In precision medicine, cancer patients are treated with drugs that target specific molecular alterations found in their cancer cells. As new drugs for specific targets emerge, possibilities expand. Our prospective clinical study explored the possibilities of receiving targeted treatm...
Autores principales: | Frank, Malene Støchkel, Bodtger, Uffe, Gehl, Julie, Ahlborn, Lise Barlebo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749927/ https://www.ncbi.nlm.nih.gov/pubmed/35008297 http://dx.doi.org/10.3390/cancers14010132 |
Ejemplares similares
-
Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non–small Cell Lung Cancer
por: Frank, Malene S., et al.
Publicado: (2022) -
Detection of copy number alterations in cell-free tumor DNA from plasma
por: Østrup, Olga, et al.
Publicado: (2017) -
Fractionated palliative thoracic radiotherapy in non-small cell lung cancer – futile or worth-while?
por: Støchkel Frank, Malene, et al.
Publicado: (2018) -
Detection of circulating tumor-derived material in peripheral blood of pediatric sarcoma patients: A systematic review
por: Kjær, Eva Kristine Ruud, et al.
Publicado: (2023) -
The impact of a personalised action plan delivered at discharge to patients with COPD on readmissions: a pilot study
por: Hegelund, Annette, et al.
Publicado: (2019)